Skip to Main Content


Skip Nav Destination

Abstract IA29: Peptide-TLR-7/8 agonist conjugate vaccines chemically programmed for nanoparticle self-assembly to enhance the magnitude and breadth of anticancer neoantigen CD8 T cell immunity

Cancer Immunol Res (2019) 7 (2_Supplement): IA29.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal